Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–7.
Article CAS PubMed PubMed Central Google Scholar
Kirwan JF, Lockwood AJ, Shah P, Macleod A, Broadway DC, King AJ, et al. Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology. 2013;120(12):2532–9.
Edmunds B, Thompson JR, Salmon JF, Wormald RP. The National Survey of Trabeculectomy. III Early and late complications Eye (Lond). 2002;16(3):297–303.
Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC, et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153(5):804-14 e1.
Article PubMed PubMed Central Google Scholar
Widder RA, Dietlein TS, Dinslage S, Kuhnrich P, Rennings C, Rossler G. The XEN45 Gel Stent as a minimally invasive procedure in glaucoma surgery: success rates, risk profile, and rates of re-surgery after 261 surgeries. Graef Arch Clin Exp. 2018;256(4):765–71.
Theilig T, Rehak M, Busch C, Bormann C, Schargus M, Unterlauft JD. Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study. Sci Rep-Uk. 2020;10(1):19337.
Chen HSL, Ritch R, Krupin T, Hsu WC. Control of filtering bleb structure through tissue bioengineering: An animal model. Invest Ophth Vis Sci. 2006;47(12):5310–4.
Hsu WC, Ritch R, Krupin T, Chen HSL. Tissue bioengineering for surgical bleb defects: an animal study. Graef Arch Clin Exp. 2008;246(5):709–17.
Cillino S, Di Pace F, Cillino G, Casuccio A. Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial. Eye (Lond). 2011;25(12):1598–606.
Yuan F, Li L, Chen XP, Yan X, Wang LY. Biodegradable 3D-Porous Collagen Matrix (Ologen) Compared with Mitomycin C for Treatment of Primary Open-Angle Glaucoma: Results at 5 Years. J Ophthalmol. 2015;2015(637537):1-7.
Senthil S, Rao HL, Babu JG, Mandal AK, Garudadri CS. Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma. Indian J Ophthalmol. 2013;61(7):338–42.
Article PubMed PubMed Central Google Scholar
Perez CI, Mellado F, Jones A, Colvin R. Trabeculectomy Combined With Collagen Matrix Implant (Ologen). J Glaucoma. 2017;26(1):54–8.
Ji QS, Qi B, Liu L, Guo XL, Zhong JX. Efficacy and Safety of Ologen Implant Versus Mitomycin C in Primary Trabeculectomy: A Meta-analysis of Randomized Clinical Trials. J Glaucoma. 2015;24(5):e88–94.
Rosentreter A, Schild AM, Jordan JF, Krieglstein GK, Dietlein TS. A prospective randomised trial of trabeculectomy using mitomycin C vs an ologen implant in open angle glaucoma. Eye. 2010;24(9):1450–6.
Kim TJ, Kang S, Jeoung JW, Kim YK, Park KH. Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant. BMC Ophthalmol. 2018;18(1):45.
Article PubMed PubMed Central Google Scholar
Sastre-Ibanez M, Cabarga C, Canut MI, Perez-Bartolome F, Urcelay-Segura JL, Cordero-Ros R, et al. Efficacy of Ologen matrix implant in Ahmed Glaucoma Valve Implantation. Sci Rep. 2019;9(1):3178.
Article PubMed PubMed Central Google Scholar
Navero-Rodriguez JM, Espinosa-Barberi G, Morilla-Grasa A, Anton A. Efficacy of the Ologen collagen matrix in combination with the XEN gel stent implantation in the treatment of open-angle glaucoma: A case-control study. Clin Exp Ophthalmol. 2020;48(7):1003–5.
Mansouri K, Guidotti J, Rao HL, Ouabas A, D’Alessandro E, Roy S, et al. Prospective Evaluation of Standalone XEN Gel Implant and Combined Phacoemulsification-XEN Gel Implant Surgery: 1-Year Results. J Glaucoma. 2018;27(2):140–7.
Poley BJ, Lindstrom RL, Samuelson TW, Schulze R Jr. Intraocular pressure reduction after phacoemulsification with intraocular lens implantation in glaucomatous and nonglaucomatous eyes: evaluation of a causal relationship between the natural lens and open-angle glaucoma. J Cataract Refract Surg. 2009;35(11):1946–55.
Shingleton BJ, Pasternack JJ, Hung JW, O’Donoghue MW. Three and five year changes in intraocular pressures after clear corneal phacoemulsification in open angle glaucoma patients, glaucoma suspects, and normal patients. J Glaucoma. 2006;15(6):494–8.
Armstrong JJ, Wasiuta T, Kiatos E, Malvankar-Mehta M, Hutnik CML. The Effects of Phacoemulsification on Intraocular Pressure and Topical Medication Use in Patients With Glaucoma: A Systematic Review and Meta-analysis of 3-Year Data. J Glaucoma. 2017;26(6):511–22.
Fea AM, Bron AM, Economou MA, Laffi G, Martini E, Figus M, et al. European study of the efficacy of a cross-linked gel stent for the treatment of glaucoma. J Cataract Refract Surg. 2020;46(3):441–50.
Lim SY, Betzler BK, Yip LWL, Dorairaj S, Ang BCH. Standalone XEN45 Gel Stent implantation versus combined XEN45-phacoemulsification in the treatment of open angle glaucoma-a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2021;259(11):3209–19.
Article CAS PubMed Google Scholar
Yang X, Zhao Y, Zhong Y, Duan X. The efficacy of XEN gel stent implantation in glaucoma: a systematic review and meta-analysis. BMC Ophthalmol. 2022;22(1):305.
Article PubMed PubMed Central Google Scholar
Panarelli JF, Yan DB, Francis B, Craven ER. XEN Gel Stent Open Conjunctiva Technique: A Practical Approach Paper. Adv Ther. 2020;37(5):2538–49.
Article PubMed PubMed Central Google Scholar
Parra MTM, Lopez JAS, Grau NSL, Ceausescu AM, Santonja JJP. XEN implant device versus trabeculectomy, either alone or in combination with phacoemulsification, in open-angle glaucoma patients. Graef Arch Clin Exp. 2019;257(8):1741–50.
Wagner FM, Schuster AKG, Emmerich J, Chronopoulos P, Hoffmann EM. Efficacy and safety of XEN (R)-Implantation vs. trabeculectomy: Data of a "real-world" setting. Plos One. 2020;15(4):e0231614 1-10.
Buffault J, Graber M, Bensmail D, Bluwol E, Jeanteur MN, Abitbol O, et al. Efficacy and safety at 6 months of the XEN implant for the management of open angle glaucoma. Sci Rep-Uk. 2020;10(1):4527 1-7.
Buffault J, Baudouin C, Labbe A. XEN((R)) Gel Stent for management of chronic open angle glaucoma: A review of the literature. J Fr Ophtalmol. 2019;42(2):e37–46.
Article CAS PubMed Google Scholar
Jampel HD, Solus JF, Tracey PA, Gilbert DL, Loyd TL, Jefferys JL, et al. Outcomes and bleb-related complications of trabeculectomy. Ophthalmology. 2012;119(4):712–22.
He M, Wang W, Zhang X, Huang W. Ologen implant versus mitomycin C for trabeculectomy: a systematic review and meta-analysis. PLoS ONE. 2014;9(1):e85782.
Article PubMed PubMed Central Google Scholar
Hollo G. Wound healing and glaucoma surgery: modulating the scarring process with conventional antimetabolites and new molecules. Dev Ophthalmol. 2012;50:79–89.
Almobarak FA, Alharbi AH, Morales J, Aljadaan I. The influence of mitomycin C concentration on the outcome of trabeculectomy in uveitic glaucoma. Int Ophthalmol. 2018;38(6):2371–9.
Vastardis I, Fili S, Perdikakis G, Kontopoulou K, Balidis M, Gatzioufas Z, et al. Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation. Eye Vision. 2021;8(1):33.
Article PubMed PubMed Central Google Scholar
Castejon MA, Teus MA, Bolivar G, Paz-Moreno-Arrones J, Castano B. Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up. J Glaucoma. 2018;27(1):50–4.
Wlaz A, Wilkos-Kuc A, Rozegnal-Madej A, Zarnowski T. Phacotrabeculectomy using collagen matrix implant (Ologen (R)) versus mitomycin C: a prospective randomized controlled trial. Acta Ophthalmol. 2019;97(6):E817–26.
Article CAS PubMed Google Scholar
Sharpe R, Pham G, Chang P. Comparison of Ab Interno XEN Gelatin Stent vs Trabeculectomy with Mitomycin C: A Retrospective Study. J Curr Glaucoma Pract. 2020;14(3):87–92.
Article PubMed PubMed Central Google Scholar
Do A, McGlumphy E, Shukla A, Dangda S, Schuman JS, Boland MV, et al. Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent. Ophthalmol Glaucoma. 2021;4(4):343–9.
Karimi A, Hopes M, Martin KR, Lindfield D. Efficacy and Safety of the Ab-interno Xen Gel Stent After Failed Trabeculectomy. J Glaucoma. 2018;27(10):864–8.
Bormann C, Schmidt M, Busch C, Rehak M, Scharenberg CT, Unterlauft JD. Implantation of XEN After Failed Trabeculectomy: an Efficient Therapy? Klin Monbl Augenheilkd. 2022;239(1):86–93.
Duzgun E, Olgun A, Karapapak M, Alkan AA, Ustaoglu M. Outcomes of XEN Gel Stent Implantation in the Inferonasal Quadrant after Failed Trabeculectomy. J Curr Glaucoma Pract. 2021;15(2):64–9.
留言 (0)